Co-Diagnostics, Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CODX Co-Diagnostics, Inc.

Trading 03-20 12:17:09 EDT

2.58

-0.07

-2.83%

High3.95	Low2.47	Vol53.88M
Open3.86	D1 Closing2.65	Amplitude55.85%
Mkt Cap5.39M	Tradable Cap5.13M	Total Shares2.10M
T/O176.52M	T/O Rate2,705.04%	Tradable Shares1.99M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CODX","market":"US","secType":"STK","nameCN":"Co-Diagnostics, Inc.","latestPrice":2.575,"timestamp":1774023429038,"preClose":2.65,"halted":0,"volume":53878892,"delay":0,"changeRate":-0.02830188679245273,"floatShares":1991800,"shares":2095000,"eps":-29.00775,"marketStatus":"Trading","change":-0.075,"latestTime":"03-20 12:17:09 EDT","open":3.86,"high":3.95,"low":2.47,"amount":176519825.5253928,"amplitude":0.558491,"askPrice":2.58,"askSize":350,"bidPrice":2.57,"bidSize":400,"shortable":3,"etf":0,"ttmEps":-29.00775,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1774036800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.65,"preHourTrading":{"tag":"盘前","latestPrice":3.8401,"preClose":2.65,"latestTime":"09:29 EDT","volume":13380448,"amount":49207823.1690368,"timestamp":1774013399576,"change":1.1901,"changeRate":0.449094,"amplitude":0.437736},"postHourTrading":{"tag":"盘后","latestPrice":2.6456,"preClose":2.65,"latestTime":"19:59 EDT","volume":19824,"amount":52012.7997,"timestamp":1773964783279,"change":-0.0044,"changeRate":-0.00166,"amplitude":0.014981},"volumeRatio":373.84574,"impliedVol":1.6193,"impliedVolPercentile":0.5327},"requestUrl":"/m/hq/s/CODX","defaultTab":"news","newsList":[{"id":"2620692735","title":"Co-Diagnostics to expand commercial, distribution territory across South Asia","url":"https://stock-news.laohu8.com/highlight/detail?id=2620692735","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620692735?lang=en_us&edition=fundamental","pubTime":"2026-03-20 20:11","pubTimestamp":1774008717,"startTime":"0","endTime":"0","summary":"Co-Diagnostics (CODX) has signed an agreement for CoSara Diagnostics, the Indian joint venture between Co-Dx and Ambalal Sarabhai Enterprises, to s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/co-diagnostics-to-expand-commercial-distribution-territory-across-south-asia-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/co-diagnostics-to-expand-commercial-distribution-territory-across-south-asia-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CODX","BK4082","BK4568"],"gpt_icon":0},{"id":"2620733458","title":"CoSara Diagnostics expands South Asia territory, targets USD 13 billion market opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2620733458","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620733458?lang=en_us&edition=fundamental","pubTime":"2026-03-20 20:02","pubTimestamp":1774008163,"startTime":"0","endTime":"0","summary":"CoSara, an Indian joint venture between Co-Dx and ASE Group, signed an agreement to expand its commercial and distribution territory in South Asia to include Bangladesh, Pakistan, Nepal, and Sri Lanka.The expanded territory increased CoSara’s estimated regional addressable market opportunity to USD 13 billion.Plans include establishing distribution channels in the newly added markets while evaluating regulatory pathways and engaging regional distribution partners.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL5xZ30s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4082","BK4568"],"gpt_icon":0},{"id":"2620733577","title":"Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia","url":"https://stock-news.laohu8.com/highlight/detail?id=2620733577","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620733577?lang=en_us&edition=fundamental","pubTime":"2026-03-20 20:00","pubTimestamp":1774008000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nTUA95VCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","CODX","BK4082"],"gpt_icon":0},{"id":"2620427468","title":"Co-Diagnostics Inc. schedules fourth-quarter and full-year 2025 earnings webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2620427468","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620427468?lang=en_us&edition=fundamental","pubTime":"2026-03-17 21:04","pubTimestamp":1773752647,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc. schedules fourth-quarter and full-year 2025 earnings webcast               Co-Diagnostics will release its fourth quarter and full year 2025 financial results on March 31, 2026, af","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL9ScK8l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4082","CODX"],"gpt_icon":0},{"id":"2619465552","title":"Co-Diagnostics to present at Medical Korea 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2619465552","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619465552?lang=en_us&edition=fundamental","pubTime":"2026-03-16 21:01","pubTimestamp":1773666080,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire  on March 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL554k5v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4082","CODX"],"gpt_icon":0},{"id":"2618068132","title":"Co-Diagnostics receives Japanese patent No. 7797537 for Co-Dx PCR platform technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2618068132","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618068132?lang=en_us&edition=fundamental","pubTime":"2026-03-12 21:08","pubTimestamp":1773320917,"startTime":"0","endTime":"0","summary":"Co-Diagnostics said the Japan Patent Office granted Japanese Patent No. 7797537 titled “Systems, Methods, and Apparatus for Automated Self-Contained Biological Analysis.” The patent includes 34 claims covering automated, self-contained biological analysis methods and apparatus used in the Co-Dx PCR Pro system, including the instrument and its test cups. Co-Diagnostics said the patent was initially registered on December 26, 2025 and was filed under the Patent Cooperation Treaty. The company also referenced an Australian patent grant in 2025 covering related Co-Dx PCR platform technologies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief on March 12, 2026","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL2rBstt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CODX","BK4568"],"gpt_icon":0},{"id":"2618928349","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:30 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2618928349","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618928349?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:30","pubTimestamp":1773235827,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:30 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nAQN2LPO7B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4082","BK4568"],"gpt_icon":0},{"id":"2618495351","title":"Co-Diagnostics Regains Compliance With Nasdaq Listing Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2618495351","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618495351?lang=en_us&edition=fundamental","pubTime":"2026-03-10 21:00","pubTimestamp":1773147658,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nTUAPBXL5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4082","CODX"],"gpt_icon":0},{"id":"2610563546","title":"Co-Diagnostics Forms Joint Venture with Arabian Eagle Manufacturing for MENA Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2610563546","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610563546?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:02","pubTimestamp":1770645731,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc. has entered into a joint venture with Arabian Eagle Manufacturing, forming CoMira Diagnostics in the Kingdom of Saudi Arabia. This partnership aims to localize the manufacturing and distribution of Co-Diagnostics' technologies and intellectual property across Saudi Arabia and 18 additional countries in the Middle East and North Africa  region. The collaboration is part of Co-Diagnostics' strategy to expand access to high-quality molecular diagnostics throughout the region.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire  on February 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDLlmVfm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4082","CODX"],"gpt_icon":0},{"id":"2609306504","title":"Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture PCR Pro Instrument in India","url":"https://stock-news.laohu8.com/highlight/detail?id=2609306504","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609306504?lang=en_us&edition=fundamental","pubTime":"2026-02-05 22:01","pubTimestamp":1770300105,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc. announced that its joint venture, CoSara Diagnostics Pvt. Ltd. , has received a license from the Central Drugs Standard Control Organization  to manufacture the CoSara PCR Pro real-time PCR point-of-care instrument at its facility in Ranoli, India. The CDSCO license, issued on Form MD-5, authorizes the manufacturing and sale or distribution of the CoSara-branded Class A medical device instrument. This represents the final instrument license required by CDSCO before commercialization can begin. CoSara PCR test kits to be used with the instrument, such as those for Mycobacterium tuberculosis  and human papillomavirus , require separate regulatory clearance and are not yet available for sale.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investme","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDLDfdBs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CODX","BK4568"],"gpt_icon":0},{"id":"2608367208","title":"CoSara Receives ISO 13485 Certification for PCR Platform Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2608367208","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608367208?lang=en_us&edition=fundamental","pubTime":"2026-02-04 22:01","pubTimestamp":1770213686,"startTime":"0","endTime":"0","summary":"CoSara Diagnostics Pvt. Ltd., an affiliate of Co-Diagnostics Inc. through its joint venture with Ambalal Sarabhai Enterprises Limited, has received ISO 13485:2016 certification for its manufacturing facility in Vadodara, India. The certification follows successful quality management system audits and is a key milestone as CoSara prepares to manufacture Co-Diagnostics' upcoming PCR platform and associated test kits.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief on February 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL7SvsF4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CODX","BK4568"],"gpt_icon":0},{"id":"2605407176","title":"Co-Diagnostics Cut to Hold From Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2605407176","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605407176?lang=en_us&edition=fundamental","pubTime":"2026-01-24 02:37","pubTimestamp":1769193420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CODX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 23, 2026 13:37 ET (18:37 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","CODX","BK4082"],"gpt_icon":0},{"id":"2605470405","title":"Co-Diagnostics downgraded to Hold from Buy at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2605470405","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605470405?lang=en_us&edition=fundamental","pubTime":"2026-01-23 21:00","pubTimestamp":1769173247,"startTime":"0","endTime":"0","summary":"Maxim downgraded Co-Diagnostics (CODX) to Hold from Buy. Published first on TheFly – the ultimate source for real-time, market-moving breaking fina...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/co-diagnostics-downgraded-to-hold-from-buy-at-maxim-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/co-diagnostics-downgraded-to-hold-from-buy-at-maxim-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","CODX","BK4082"],"gpt_icon":0},{"id":"2603631985","title":"Co-Diagnostics trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2603631985","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603631985?lang=en_us&edition=fundamental","pubTime":"2026-01-14 01:30","pubTimestamp":1768325417,"startTime":"0","endTime":"0","summary":"12:29 EST Co-Diagnostics (CODX) trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial new...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/co-diagnostics-trading-resumes-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/co-diagnostics-trading-resumes-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4082","CODX"],"gpt_icon":0},{"id":"2603263189","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 12:24 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2603263189","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603263189?lang=en_us&edition=fundamental","pubTime":"2026-01-14 01:24","pubTimestamp":1768325080,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 12:24 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nAQN2LHI6H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4082","CODX"],"gpt_icon":0},{"id":"2603894631","title":"Nasdaq Moves to Delist Co-Diagnostics Inc. Over Bid Price Non-Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2603894631","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603894631?lang=en_us&edition=fundamental","pubTime":"2026-01-14 01:23","pubTimestamp":1768325039,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc. faces a potential delisting from the Nasdaq Capital Market due to non-compliance with Nasdaq’s minimum bid price requirement, which mandates a closing bid price of at least $1.00 per share. Despite implementing a 1-for-30 reverse stock split effective January 2, 2026, to increase its share price, the company failed to maintain the required bid price for the necessary period, prompting Nasdaq to issue a delisting notice. Co-Diagnostics plans to request a hearing to contest the delisting, but its shares are scheduled to be suspended from Nasdaq trading on January 14, 2026, and are expected to move to the OTC Market. The company may still seek reinstatement if it demonstrates compliance by maintaining the minimum bid price for 10 consecutive business days.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDLvVSjD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4568","BK4082"],"gpt_icon":0},{"id":"2602543783","title":"CoSara Expands Distributor Network Across India for Co-Diagnostics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2602543783","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602543783?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:01","pubTimestamp":1768226496,"startTime":"0","endTime":"0","summary":"CoSara Diagnostics, Co-Diagnostics Inc. Subsidiary, Expands Distributor Network and Showcases Products at Regional Indian Conferences. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire  on January 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL5V3GQJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","CODX","BK4082"],"gpt_icon":0},{"id":"2595902837","title":"Co-Diagnostics Enacts 1-for-30 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2595902837","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595902837?lang=en_us&edition=fundamental","pubTime":"2025-12-30 22:00","pubTimestamp":1767103223,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc. has announced a 1-for-30 reverse stock split of its common stock, effective January 2, 2026. The move aims to help the company regain compliance with Nasdaq’s minimum bid price requirement. Co-Diagnostics shares will continue to trade under the symbol CODX on a split-adjusted basis starting January 2, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire  on December 30, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL8ZDgrT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4568","BK4082"],"gpt_icon":0},{"id":"2595902287","title":"Co-Diagnostics Inc - Reverse Stock Split Effective January 2, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2595902287","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595902287?lang=en_us&edition=fundamental","pubTime":"2025-12-30 22:00","pubTimestamp":1767103200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nTUABFCTGY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CODX","BK4568"],"gpt_icon":0},{"id":"2595790490","title":"Co-Diagnostics Inc - Filed Amendment to Effect Reverse Stock Split of Its Common Stock at a Ratio of 1-for-30 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2595790490","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595790490?lang=en_us&edition=fundamental","pubTime":"2025-12-30 22:00","pubTimestamp":1767103200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nTUABFCTGY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CODX","BK4568"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.codiagnostics.com","stockEarnings":[{"period":"1week","weight":0.0076},{"period":"1month","weight":0.0643},{"period":"3month","weight":-0.6653},{"period":"6month","weight":-0.7983},{"period":"1year","weight":-0.8138},{"period":"ytd","weight":-0.4761}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0338},{"period":"3month","weight":-0.0305},{"period":"6month","weight":-0.0059},{"period":"1year","weight":0.1634},{"period":"ytd","weight":-0.0324}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.280232},{"month":2,"riseRate":0.222222,"avgChangeRate":0.209425},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.14104},{"month":4,"riseRate":0.375,"avgChangeRate":0.008039},{"month":5,"riseRate":0.375,"avgChangeRate":0.046537},{"month":6,"riseRate":1,"avgChangeRate":0.106921},{"month":7,"riseRate":0.625,"avgChangeRate":0.172835},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.06719},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.02377},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.003584},{"month":11,"riseRate":0.222222,"avgChangeRate":-0.082815},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.196965}],"exchange":"NASDAQ","name":"Co-Diagnostics, Inc.","nameEN":"Co-Diagnostics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Co-Diagnostics, Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Co-Diagnostics, Inc.(CODX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Co-Diagnostics, Inc.,CODX,Co-Diagnostics, Inc.股票,Co-Diagnostics, Inc.股票老虎,Co-Diagnostics, Inc.股票老虎国际,Co-Diagnostics, Inc.行情,Co-Diagnostics, Inc.股票行情,Co-Diagnostics, Inc.股价,Co-Diagnostics, Inc.股市,Co-Diagnostics, Inc.股票价格,Co-Diagnostics, Inc.股票交易,Co-Diagnostics, Inc.股票购买,Co-Diagnostics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Co-Diagnostics, Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Co-Diagnostics, Inc.(CODX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}